companydata.dkENDOGEN ApS: Financial statements 2017
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 0 and a net result of DKK -7,059 compared with DKK -13,532 the year before. Equity amounted to DKK 35,530. The solvency ratio was 100%.
- Revenue
- 0 kr.
- Gross Profit
- -6,859 kr.
- Profit/Loss
- -7,059 kr.
- Equity
- 35,530 kr.
- Total Assets
- 35,530 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 0 | -7 t. | -7 t. | 36 t. | - |
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
Find more companies like ENDOGEN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
ENDOGEN ApS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK -13,532.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.